GeNepher data- and biobank for patients with (suspected) genetic kidney disease: Rationale, design and status update

Background: Clinical research on monogenic kidney disease (MKD) is thriving and the need for large cohorts, prospective data collection and biobanking is increasing. We aim to create a sustainable large MKD biobank with a vast amount of uniformly collected high-quality data that is readily available...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura R. Claus, Iris Lekkerkerker, Bert van der Zwaag, Tri Q. Nguyen, Nine V.A.M. Knoers, Martin H. de Borst, Maarten B. Rookmaker, Marc R. Lilien, Albertien M. van Eerde
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Rare
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2950008724000139
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846117508551016448
author Laura R. Claus
Iris Lekkerkerker
Bert van der Zwaag
Tri Q. Nguyen
Nine V.A.M. Knoers
Martin H. de Borst
Maarten B. Rookmaker
Marc R. Lilien
Albertien M. van Eerde
author_facet Laura R. Claus
Iris Lekkerkerker
Bert van der Zwaag
Tri Q. Nguyen
Nine V.A.M. Knoers
Martin H. de Borst
Maarten B. Rookmaker
Marc R. Lilien
Albertien M. van Eerde
author_sort Laura R. Claus
collection DOAJ
description Background: Clinical research on monogenic kidney disease (MKD) is thriving and the need for large cohorts, prospective data collection and biobanking is increasing. We aim to create a sustainable large MKD biobank with a vast amount of uniformly collected high-quality data that is readily available for future research, with an infrastructure that allows for recontacting participants. Methods: The GeNepher data- and biobank is an ongoing data- and sample collection that includes patients and family members with known and/or suspected MKD. With a tiered approach participants can give broad consent for including their 1) available medical data (including genetic testing results), 2) inclusion of massively parallel sequencing data for add-on analysis, and 3) additional biobank sampling (e.g. urine for tubuloids, skin biopsy for fibroblasts). Recontacting is possible for additional data collection, novel research opportunities and return of relevant findings. Discussion: The GeNepher data- and biobank collects prospective and retrospective data from kidney disease patients and their relatives. The broad consent allows for research that extends beyond one specific research question. Herewith, this biobank aims to 1) increase the scientific knowledge based on disease mechanisms including (novel) monogenic causes, 2) study modifiers, 3) improve care, including reproduction related research questions. Furthermore, it facilitates recontacting for opportunities in treatment development or when diagnose specific trials are started or specific treatment is approved. Conclusion: The GeNepher biobank is designed to support a wide range of research projects by providing access to a diverse population of patients with (suspected) MKD and has the potential to make a significant contribution to the field of rare kidney disease research.
format Article
id doaj-art-9b7fa0bb5f9b4ad99c11708fe4eb1b1f
institution Kabale University
issn 2950-0087
language English
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Rare
spelling doaj-art-9b7fa0bb5f9b4ad99c11708fe4eb1b1f2024-12-18T08:55:34ZengElsevierRare2950-00872024-01-012100030GeNepher data- and biobank for patients with (suspected) genetic kidney disease: Rationale, design and status updateLaura R. Claus0Iris Lekkerkerker1Bert van der Zwaag2Tri Q. Nguyen3Nine V.A.M. Knoers4Martin H. de Borst5Maarten B. Rookmaker6Marc R. Lilien7Albertien M. van Eerde8Department of Genetics, University Medical Center Utrecht, Utrecht, the NetherlandsDepartment of Genetics, University Medical Center Utrecht, Utrecht, the NetherlandsDepartment of Genetics, University Medical Center Utrecht, Utrecht, the NetherlandsDepartment of Pathology, University Medical Center Utrecht, Utrecht, the NetherlandsDepartment of Genetics, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsDepartment of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, the NetherlandsDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, the NetherlandsDepartment of Pediatric Nephrology, Wilhelmina Children's Hospital, University Medical Center Utrecht, the NetherlandsDepartment of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands; Corresponding author at: PO Box 85090; internal mail no. KC.04.084.2, Utrecht 3508 AB, the Netherlands.Background: Clinical research on monogenic kidney disease (MKD) is thriving and the need for large cohorts, prospective data collection and biobanking is increasing. We aim to create a sustainable large MKD biobank with a vast amount of uniformly collected high-quality data that is readily available for future research, with an infrastructure that allows for recontacting participants. Methods: The GeNepher data- and biobank is an ongoing data- and sample collection that includes patients and family members with known and/or suspected MKD. With a tiered approach participants can give broad consent for including their 1) available medical data (including genetic testing results), 2) inclusion of massively parallel sequencing data for add-on analysis, and 3) additional biobank sampling (e.g. urine for tubuloids, skin biopsy for fibroblasts). Recontacting is possible for additional data collection, novel research opportunities and return of relevant findings. Discussion: The GeNepher data- and biobank collects prospective and retrospective data from kidney disease patients and their relatives. The broad consent allows for research that extends beyond one specific research question. Herewith, this biobank aims to 1) increase the scientific knowledge based on disease mechanisms including (novel) monogenic causes, 2) study modifiers, 3) improve care, including reproduction related research questions. Furthermore, it facilitates recontacting for opportunities in treatment development or when diagnose specific trials are started or specific treatment is approved. Conclusion: The GeNepher biobank is designed to support a wide range of research projects by providing access to a diverse population of patients with (suspected) MKD and has the potential to make a significant contribution to the field of rare kidney disease research.http://www.sciencedirect.com/science/article/pii/S2950008724000139Monogenic kidney diseaseBiobankGeneticsTranslational nephrogenetics
spellingShingle Laura R. Claus
Iris Lekkerkerker
Bert van der Zwaag
Tri Q. Nguyen
Nine V.A.M. Knoers
Martin H. de Borst
Maarten B. Rookmaker
Marc R. Lilien
Albertien M. van Eerde
GeNepher data- and biobank for patients with (suspected) genetic kidney disease: Rationale, design and status update
Rare
Monogenic kidney disease
Biobank
Genetics
Translational nephrogenetics
title GeNepher data- and biobank for patients with (suspected) genetic kidney disease: Rationale, design and status update
title_full GeNepher data- and biobank for patients with (suspected) genetic kidney disease: Rationale, design and status update
title_fullStr GeNepher data- and biobank for patients with (suspected) genetic kidney disease: Rationale, design and status update
title_full_unstemmed GeNepher data- and biobank for patients with (suspected) genetic kidney disease: Rationale, design and status update
title_short GeNepher data- and biobank for patients with (suspected) genetic kidney disease: Rationale, design and status update
title_sort genepher data and biobank for patients with suspected genetic kidney disease rationale design and status update
topic Monogenic kidney disease
Biobank
Genetics
Translational nephrogenetics
url http://www.sciencedirect.com/science/article/pii/S2950008724000139
work_keys_str_mv AT laurarclaus genepherdataandbiobankforpatientswithsuspectedgenetickidneydiseaserationaledesignandstatusupdate
AT irislekkerkerker genepherdataandbiobankforpatientswithsuspectedgenetickidneydiseaserationaledesignandstatusupdate
AT bertvanderzwaag genepherdataandbiobankforpatientswithsuspectedgenetickidneydiseaserationaledesignandstatusupdate
AT triqnguyen genepherdataandbiobankforpatientswithsuspectedgenetickidneydiseaserationaledesignandstatusupdate
AT ninevamknoers genepherdataandbiobankforpatientswithsuspectedgenetickidneydiseaserationaledesignandstatusupdate
AT martinhdeborst genepherdataandbiobankforpatientswithsuspectedgenetickidneydiseaserationaledesignandstatusupdate
AT maartenbrookmaker genepherdataandbiobankforpatientswithsuspectedgenetickidneydiseaserationaledesignandstatusupdate
AT marcrlilien genepherdataandbiobankforpatientswithsuspectedgenetickidneydiseaserationaledesignandstatusupdate
AT albertienmvaneerde genepherdataandbiobankforpatientswithsuspectedgenetickidneydiseaserationaledesignandstatusupdate